Keynote Points:
Links diagnostic tests to targeted cancer therapies
Identifies biomarkers and genetic/molecular tumor profiles
Supports precision and personalized oncology treatment
Integrates with clinical workflows for therapy selection and monitoring
Enhances multidisciplinary cancer care and decision-making
Benefits:
Improves treatment effectiveness and patient outcomes
Reduces adverse effects through targeted therapy selection
Enables early detection, monitoring, and therapy adjustment
Supports precision medicine and individualized cancer care
Drives innovation in oncology diagnostics and therapeutics
Upload here: https://pathology-medicine.utilitarianevents.com/upload-presentation/
WhatsApp: https://wa.me/+971551792927
Email: pathology@utilitarian-events.com
Description:
Oncology & Companion Diagnostics focus on linking specific diagnostic tests with targeted cancer therapies to enable precision medicine. Companion diagnostics identify biomarkers, genetic mutations, or molecular profiles in tumors, guiding clinicians in selecting the most effective treatment for individual patients. This approach improves therapeutic outcomes, minimizes adverse effects, and supports personalized oncology care.
This session will explore advances in biomarker discovery, molecular profiling, liquid biopsies, and regulatory frameworks for companion diagnostics. Discussions will highlight how integrating companion diagnostics into clinical workflows enables early detection, treatment stratification, therapy monitoring, and multidisciplinary decision-making, ultimately enhancing patient-centered cancer care and driving innovation in precision oncology.